iSERA Lifesciences Stock Price Analysis and Quick Research Report. Is iSERA Lifesciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse iSERA Lifesciences. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). iSERA Lifesciences has a PE ratio of -876.390773405699 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. iSERA Lifesciences has ROA of 17.283% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. iSERA Lifesciences has a Current ratio of 33.7028.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. iSERA Lifesciences has a ROE of 0%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. iSERA Lifesciences has a Debt to Equity ratio of -16.3837 which means that the company has low proportion of debt in its capital.

• Sales growth: iSERA Lifesciences has reported revenue growth of 0% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of iSERA Lifesciences for the current financial year is 52.4132730015083%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for iSERA Lifesciences is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of iSERA Lifesciences is Rs -0.0737. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of iSERA Lifesciences in Ticker for free. Also, one can get the intrinsic value of iSERA Lifesciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

iSERA Lifesciences FAQs

Q1. What is iSERA Lifesciences share price today?
Ans: The current share price of iSERA Lifesciences is Rs 64.59.

Q2. What is the market capitalisation of iSERA Lifesciences?
Ans: iSERA Lifesciences has a market capitalisation of Rs 54.313550148 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of iSERA Lifesciences?
Ans: The PE ratio of iSERA Lifesciences is -876.390773405699 and the P/B ratio of iSERA Lifesciences is 7.05593183307844, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of iSERA Lifesciences share?
Ans: The 52-week high share price of iSERA Lifesciences is Rs 64.59, and the 52-week low share price of iSERA Lifesciences is Rs 1.5.

Q5. Does iSERA Lifesciences pay dividends?
Ans: Currently, iSERA Lifesciences does not pay dividends. Dividend yield of iSERA Lifesciences is around 0%.

Q6. What are the face value and book value of iSERA Lifesciences shares?
Ans: The face value of iSERA Lifesciences shares is Rs 10, while the book value per share of iSERA Lifesciences is around Rs 9.154. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of iSERA Lifesciences?
Ans: iSERA Lifesciences has a total debt of Rs 1.6056 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of iSERA Lifesciences?
Ans: The ROE of iSERA Lifesciences is 0% and ROCE of iSERA Lifesciences is 18.8233%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is iSERA Lifesciences a good buy for the long term?
Ans: The iSERA Lifesciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is iSERA Lifesciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the iSERA Lifesciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check iSERA Lifesciences’s financials?
Ans: You can review iSERA Lifesciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.